Likewise directors are buying shares and building new logistics capacity as the company pushes forward with growth plans despite near-term profit pressures...
AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
Strix Group has issued a trading update confirming stable revenue, early signs of recovery in its Controls division, continued strong performance from Billi, and renewed growth in Consumer Goods...
Avation will hold its AGM in Singapore today, where the Chairman will outline steady fleet activity, stable lease income, ongoing aircraft placements, and a stronger financial position following recent refinancing...
Cerillion’s Louis Hall breaks down a record year of performance, including a major new market entry in Armenia and a £25m expansion in Europe. With a robust order pipeline and shrinking competition, Cerillion is well-positioned to build on its momentum heading into FY26...
Likewise directors are buying shares and building new logistics capacity as the company pushes forward with growth plans despite near-term profit pressures...
AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
Strix Group has issued a trading update confirming stable revenue, early signs of recovery in its Controls division, continued strong performance from Billi, and renewed growth in Consumer Goods...
Avation will hold its AGM in Singapore today, where the Chairman will outline steady fleet activity, stable lease income, ongoing aircraft placements, and a stronger financial position following recent refinancing...
Cerillion’s Louis Hall breaks down a record year of performance, including a major new market entry in Armenia and a £25m expansion in Europe. With a robust order pipeline and shrinking competition, Cerillion is well-positioned to build on its momentum heading into FY26...
